SCHEMBL28452438

SCHEMBL28452438

C[C@@H]1CCC2(CCN(C(=O)OC(C)(C)C)CC2)[C@@H]1NS(=O)(=O)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 6/20 0.40
▸ EPHX1 P07099 1/20 0.40
▸ HPGD P15428 1/20 0.39
▸ EPHX2 P34913 1/20 0.38
▸ STS P08842 6/20 0.38
▸ USP2 O75604 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31184417 1.00 GPR119 (0.40) GPR119EPHX1HPGDEPHX2STS
SCHEMBL31184121 0.88 GPR119 (0.39) GPR119EPHX1HPGDEPHX2STS
SCHEMBL28446272 0.88 GPR119 (0.39) GPR119EPHX1HPGDEPHX2STS
SCHEMBL28456488 0.86 NAMPT (0.31) —
SCHEMBL31184402 0.82 GPR119 (0.38) GPR119EPHX1EPHX2USP2SMN1; SMN2
SCHEMBL28360243 0.82 GPR119 (0.38) GPR119EPHX1EPHX2USP2SMN1; SMN2
SCHEMBL28448337 0.82 GPR119 (0.38) GPR119EPHX1EPHX2USP2SMN1; SMN2
SCHEMBL29564055 0.82 GPR119 (0.38) GPR119EPHX1EPHX2USP2SMN1; SMN2
SCHEMBL28356333 0.82 GPR119 (0.38) GPR119EPHX1EPHX2USP2SMN1; SMN2
SCHEMBL29715656 0.81 EPHX1 (0.42) GPR119EPHX1HPGDEPHX2STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112625028-A Compounds and compositions for inhibiting SHP2 activity 诺华股份有限公司 2021-04-09 — — CN disclosed
CN-107922388-B Compounds and compositions for inhibiting SHP2 activity 诺华股份有限公司 2020-12-29 — — CN disclosed
CN-107787323-B Compounds and compositions for inhibiting SHP2 activity 诺华股份有限公司 2020-09-01 — — CN disclosed
Send feedback